Nanjing Leads Biolabs Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	12,520	10,143	-	-
Enterprise Value	11,110	9,977	-	-
Last Close Price	62.95	51.00	-	-
PS Ratio	63.47	51.42	-	-
PB Ratio	8.89	7.20	-	-
P/TBV Ratio	8.90	7.21	-	-
EV/Sales Ratio	56.32	50.58	-	-
Debt / Equity Ratio	0.22	0.22	1.00	-0.07
Net Debt / Equity Ratio	-1.00	-1.00	-1.02	0.30
Net Debt / EBITDA Ratio	7.09	7.09	1.08	1.15
Net Debt / FCF Ratio	7.79	7.79	2.24	1.37
Asset Turnover	0.14	0.14	-	-
Quick Ratio	3.08	3.08	1.35	0.25
Current Ratio	3.37	3.37	1.50	0.26
Return on Equity (ROE)	-27.61%	-27.61%	-	-
Return on Assets (ROA)	-9.92%	-9.92%	-30.59%	-
Return on Capital Employed (ROCE)	-15.20%	-15.20%	-100.80%	27.80%
Earnings Yield	-1.88%	-2.32%	-	-
FCF Yield	-1.45%	-1.78%	-	-
Buyback Yield / Dilution	-16.10%	-16.10%	-3.56%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.